RE: Another 3 million shares23 Sep 2023 08:50
Well, if they’ve managed any product registrations in any EU countries we’ve not been told about it. As far as I’m aware they still cannot sell AIHL or CYP2C19 anywhere other than the UK. They have numerous distribution partners but for some reason not one of them is selling anything for GDR yet.
If Cheek can get another placing away at 6p which covers the cost of an application for the US market then that will improve the long term picture but it’lltake a couple of years minimum. Starres was right in predicting global sales was several years off. I thought he’d gone rogue but once I looked into it all it became obvious Budd simply wasn’t being straight with share holders about the length of time it takes to get into such markets and achieve proper established and regular revenue .
RF must have been heavily involved in getting Budd out and so one positive thing for existing share holders to latch on to is that they want and need to see GDR succeed, or at least to some degree. That can only be good for share holders as they will help point the GDR management team in the right direction as to date Budd and Gilham have been pretty clueless